Feature Article Lipid disorders Lipid management – what counts, what is new? CardiologyToday October 2021 2021; 11(2): 66-70
Regular Series Perspectives Statin intolerance in people with diabetes: a clinical approach EndocrinologyToday May 2018 2018; 7(2): 34-36
Feature Article Lipid metabolism disorders Intensive lipid-modifying therapy: why, when, who and how? CardiologyToday July 2017 2017; 7(1): 11-14
Regular Series Case studies Familial hypercholesterolaemia: detect in an individual, treat the extended family CardiologyToday March 2016 2016; 6(1): 31-33
Regular Series Perspectives What comes before coronary artery disease? Defining atheroma burden CardiologyToday June 2015 2015; 5(2): 22-24
Regular Series Perspectives Statin therapy and dysglycaemia: is this clinically important? EndocrinologyToday May 2015 2015; 4(3): 31-33
Regular Series Case studies The patient had side effects with statins: should she receive other therapy? CardiologyToday March 2015 2015; 5(1): 34-35
Regular Series Case studies Statin-associated muscle adverse events: some key issues explored CardiologyToday November 2014 2014; 4(4): 31-33
Regular Series Investigations in endocrinology Lipid and lipoprotein testing in diabetes EndocrinologyToday October 2014 2014; 3(5): 35-37
Regular Series Case studies Challenging cases in lipid management and CVD prevention: a retrospective and an update CardiologyToday September 2014 2014; 4(3): 29-33
Regular Series Perspectives New developments in coronary stent technology CardiologyToday June 2014 2014; 4(2): 14-16
Regular Series Perspectives Coronary artery disease: what is the role of inflammation? CardiologyToday June 2014 2014; 4(2): 18-19
Regular Series Case studies New treatment for a patient who could not tolerate statins CardiologyToday June 2014 2014; 4(2): 24-26
Regular Series Case studies Should statins be prescribed for elderly patients? CardiologyToday November 2013 2013; 3(4): 34-35
Clinical Flowchart Cardiovascular medicine Managing dyslipidaemia in patients at high risk of CVD CardiologyToday November 2013 2013; 3(4): 8-15
Feature Article Cardiovascular medicine Grappling with hypertriglyceridaemia: Rosetta Stone or Pandora’s Box? CardiologyToday November 2013 2013; 3(4): 8-15
Regular Series Perspectives Fibrate therapy for dyslipidaemia and prevention of cardiovascular disease CardiologyToday September 2013 2013; 3(3): 14-18
Regular Series Case studies A patient on statin therapy experiencing myalgia but having two diagnoses CardiologyToday September 2013 2013; 3(3): 33-35
Regular Series Case studies Father and daughter with the same cholesterol problem CardiologyToday June 2013 2013; 3(2): 33-34
Regular Series Perspectives Dyslipidaemia in diabetes: a common problem worth treating to target EndocrinologyToday April 2013 2013; 2(2): 24-29
Regular Series Case studies Extreme hypertriglyceridaemia: a tale of two patients CardiologyToday March 2013 2013; 3(1): 27-28
Feature Article Pharmacology and therapeutics Managing myopathy in the statin-intolerant patient CardiologyToday November 2012 2012; 2(4): 15-19
Regular Series Case studies A patient with familial hypercholesterolaemia unable to achieve target LDL-cholesterol levels CardiologyToday November 2012 2012; 2(4): 29-30
Regular Series Case studies Diabetes has developed while the patient was taking a statin: a concerned patient CardiologyToday September 2012 2012; 2(3): 34-35
